(A) Stable basal synaptic transmission was recorded from WT or Δp35KI hippocampal slices for at least 15 min, followed by incubation in Aβ1-42 (0.2 μM) for 40 min. Scale bars, 0.5 mV and 10 ms. Sample traces represent fEPSPs at 1 min before (gray) and 40 min after (black) Aβ1-42 treatment. Right: the magnitude of Aβ1-42-induced depression was calculated by comparing the average slopes of fEPSPs during the last 10 min of recordings with those obtained before Aβ1-42 treatment (WT: 8.8%± 3.3%, 7 slices from 3 mice; Δp35KI: 1.2% ± 2.4%, 6 slices from 3 mice). Student's t test.
(B) Levels of p25 in WT and Δp35KI hippocampus after incubation with Aβ1-42. Δp35 expression in Δp35KI hippocampus was confirmed by immunoblotting with an anti-HA antibody. The asterisk represents a nonspecific background band. Right: the bar graph represents relative immunoreactivity of p25/p35 compared with the WT untreated group (n = 5 per group; Student's t test).
(C) IP-linked Cdk5 kinase assays were performed on WT, 5XFAD, Δp35KI, or 5XFAD;Δp35KI hippocampal lysates (n = 5 per group).
(D) The relative immunoreactivity of DARPP-32 pThr75/total DARPP-32 was normalized to WT (n = 4–6 per group; p < 0.01 by ANOVA).
(E) The relative immunoreactivity of GluA1 pSer845/total GluA1 was normalized to WT (n = 3 per group; p < 0.01 by ANOVA). *p < 0.05, **p < 0.01, ***p < 0.001 by Student's t test or Tukey's post hoc analysis; error bars ± SEM. See also Figure S5.